Articles by James Calloway
Douglas Dynamics Rebounds on Margin Optimism
Shares of Douglas Dynamics (NYSE:PLOW) gained 3.7% last week, beating the Russell 2000 by 4.2 percentage points, as the market focuses on margin expansion prospects.
Iovance Biotherapeutics Soars 18% as Amtagvi Sales Target Nears
Iovance Biotherapeutics (IOVA) shares jumped 18% as investors focus on the upcoming sales test for Amtagvi, with second-quarter revenue guidance of $86-$88 million.
CSL Faces US$650M Revenue Headwinds Ahead of August Earnings Report
CSL Limited (ASX:CSL) disclosed three major revenue headwinds totaling US$650 million, representing 4.3% of FY26 forecast, as it prepares for its August 18 earnings report.
Ford's Warranty Accruals Drop 18.7%, Cash Outflows Rise: Quality Push Shows
Ford's Q1 warranty accruals fell 18.7% year-over-year, but cash payments for warranties rose 2.1%. The divergence highlights quality gains yet to hit cash flow.
AT&T Faces Crucial Cash Flow Test Ahead of Q2 Earnings Report
AT&T's stock reversed early gains ahead of Q2 earnings, with free cash flow targets under scrutiny. The company needs $11.25B in the second half to meet its $18B minimum.
SoFi Stock Rebounds on Deposit Cost Advantage Ahead of Q2 Report
SoFi shares rebounded 5.5% from a session low, closing midday up 0.4%. Deposit funding advantages, saving $621.8M annually, support 75% of 2026 adjusted net income target.
Netflix Misses Q3 Forecast, Buybacks Mask Slowing Growth
Netflix shares fell 7.3% after its Q3 revenue and EPS forecasts narrowly missed analyst expectations, with buybacks reaching a record $4.71 billion in Q2.
GE Aerospace Rises as Focus Shifts to Repair Shops
GE Aerospace shares rose 3.1% after a 4.1% decline, as attention turns to repair shop capacity with Q3 spare-parts revenue 95% backlogged.
Opendoor Stock Climbs 27% in Two Days as Earnings Season Nears
Opendoor shares surged 27% over two days, with trading volume reaching 26.9% of outstanding shares. Investors focus on upcoming earnings as housing market challenges persist.
Intuitive Surgical Stock Dips on Slower H2 Growth Outlook Despite Q2 Beat
Intuitive Surgical shares dropped 11.3% premarket as the company's outlook for slower second-half da Vinci procedure growth overshadowed a strong Q2 earnings beat.